IRIS UniCatt

Chiusolo, Patrizia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.432
AS - Asia 8.943
EU - Europa 8.624
SA - Sud America 1.740
AF - Africa 280
OC - Oceania 188
Continente sconosciuto - Info sul continente non disponibili 9
AN - Antartide 1
Totale 32.217
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.992
SG - Singapore 3.904
DE - Germania 2.414
CN - Cina 2.184
IT - Italia 1.647
BR - Brasile 1.397
SE - Svezia 1.157
VN - Vietnam 815
FR - Francia 771
GB - Regno Unito 572
UA - Ucraina 410
IN - India 406
IE - Irlanda 333
FI - Finlandia 285
ID - Indonesia 277
BD - Bangladesh 247
CA - Canada 242
JP - Giappone 220
PL - Polonia 203
RU - Federazione Russa 187
AU - Australia 164
HK - Hong Kong 163
NL - Olanda 134
AR - Argentina 132
MX - Messico 123
TR - Turchia 118
KR - Corea 103
IQ - Iraq 94
ES - Italia 76
AT - Austria 75
SA - Arabia Saudita 59
ZA - Sudafrica 59
CI - Costa d'Avorio 55
BE - Belgio 53
EC - Ecuador 46
VE - Venezuela 38
PK - Pakistan 37
CH - Svizzera 35
CZ - Repubblica Ceca 35
IR - Iran 35
UZ - Uzbekistan 34
CL - Cile 33
MA - Marocco 32
CO - Colombia 31
EG - Egitto 29
RO - Romania 28
TH - Thailandia 25
DZ - Algeria 24
LT - Lituania 23
UY - Uruguay 23
AE - Emirati Arabi Uniti 22
NZ - Nuova Zelanda 22
PH - Filippine 22
IL - Israele 21
KE - Kenya 20
PY - Paraguay 20
HU - Ungheria 19
NP - Nepal 19
PT - Portogallo 18
BG - Bulgaria 17
MY - Malesia 16
JO - Giordania 15
SK - Slovacchia (Repubblica Slovacca) 14
PE - Perù 13
RS - Serbia 13
AZ - Azerbaigian 12
CR - Costa Rica 12
GR - Grecia 12
LB - Libano 12
ET - Etiopia 11
JM - Giamaica 11
NO - Norvegia 11
TN - Tunisia 11
TT - Trinidad e Tobago 11
TW - Taiwan 11
HR - Croazia 10
KZ - Kazakistan 10
EE - Estonia 9
SN - Senegal 9
AL - Albania 8
AM - Armenia 8
BA - Bosnia-Erzegovina 8
DK - Danimarca 8
DO - Repubblica Dominicana 8
HN - Honduras 8
KG - Kirghizistan 8
LV - Lettonia 8
OM - Oman 8
QA - Qatar 8
MD - Moldavia 7
GE - Georgia 6
AO - Angola 5
BH - Bahrain 5
BO - Bolivia 5
BY - Bielorussia 5
BZ - Belize 5
PA - Panama 5
EU - Europa 4
IS - Islanda 4
PR - Porto Rico 4
Totale 32.137
Salva come PNG Salva come JPEG
Città #
Singapore 2.113
Ashburn 1.145
Chandler 1.057
San Jose 1.003
Beijing 434
Los Angeles 344
Rome 330
Dublin 324
Jacksonville 301
Hefei 296
Milan 282
New York 268
Ho Chi Minh City 253
Dearborn 243
Jakarta 241
Lauterbourg 229
San Mateo 228
Hanoi 220
Munich 204
Houston 200
Tokyo 198
Nanjing 179
Dallas 173
Ann Arbor 169
Frankfurt am Main 168
Wilmington 165
Boston 156
Warsaw 156
Hong Kong 141
Chicago 140
The Dalles 137
Hyderabad 135
Seattle 121
São Paulo 121
Council Bluffs 117
Woodbridge 117
Fairfield 114
Nürnberg 114
Moscow 112
Helsinki 107
Redwood City 107
Santa Clara 106
Buffalo 101
Lancaster 99
Boardman 97
Seoul 92
Cattolica 89
Marseille 85
Nanchang 85
Orem 84
Kent 83
Princeton 83
Bremen 71
Lawrence 70
St Louis 70
Atlanta 66
Shanghai 63
London 61
San Francisco 60
Florence 59
Toronto 59
Phoenix 58
Denver 57
Abidjan 55
Brooklyn 55
Nuremberg 54
Paris 54
Redmond 53
Izmir 51
Lappeenranta 51
Tianjin 50
Brussels 49
Guangzhou 46
Kunming 46
Rio de Janeiro 46
Chennai 43
Poplar 42
Da Nang 39
Montreal 39
Amsterdam 38
Belo Horizonte 37
Cambridge 36
Mexico City 36
Philadelphia 36
Sydney 36
Johannesburg 35
Vienna 35
Stockholm 34
Turku 34
Portland 33
Shenyang 33
Norwalk 32
Haiphong 31
Melbourne 31
Naples 31
Pune 31
Hangzhou 30
Tashkent 30
Washington 30
Baghdad 28
Totale 15.830
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 3.700
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 434
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: An open-label, multicentre, randomised, phase 3 trial 385
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 383
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 290
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 235
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 230
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 223
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 216
Correlation between paraproteinaemia and viral reactivation after allo-SCT 216
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 211
Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study 198
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 193
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 189
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 186
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 185
Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia 184
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 183
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 181
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 181
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 180
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 179
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 177
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 177
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 176
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 176
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 175
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 174
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 171
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 171
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 170
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 170
Work related acute leukemia and mucor mycosis in a boat-builder 169
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 167
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 165
Hyperleukocytosis and leukostasis: management of a medical emergency 164
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 164
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 161
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 161
Neurologic improvement after peripheral blood stem cell transplantation in poems 160
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 160
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 159
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 159
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 158
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication. 157
Retrospective comparison of qualitative and quantitative reverse transcriptase polymerase chain reaction in diagnosing and monitoring the ALL1-AF4 fusion transcript in patients with acute lymphoblastic leukaemia. 156
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 156
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 155
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 155
AB0 type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients 152
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 152
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 152
MTHFR polymorphisms and vitamin B12 deficiency: correlation between mthfr polymorphisms and clinical and laboratory findings 151
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 150
MTHFR polymorphisms involved in vitamin B12 deficiency associated with atrophic gastritis 149
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 149
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 149
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease 148
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 148
Hyperleukocytosis and leukostasis: management of a medical emergency 147
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 147
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 147
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 144
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 144
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 142
Aggiornamenti di Diagnostica Molecolare in Ematologia 141
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 140
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 139
Non-tunnelled central venous catheters in adult stem cell transplantation recipients: an effective option 138
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 138
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. 137
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 136
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 136
Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease 136
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 135
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 135
Red Blood Cell Exchange as a Valid Therapeutic Approach for Pregnancy Management in Sickle Cell Disease: Three Explicative Cases and Systematic Review of Literature 133
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 133
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 133
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 132
Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal 132
Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: Monocentric observational study and review of the literature 131
Digital morphology compared to the optical microscope: A validation study on reporting bone marrow aspirates 130
Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial 129
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 129
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 128
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 127
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial 127
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 127
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes 126
Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review 125
Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation 123
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 123
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 123
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 123
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 122
UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen 121
The C807T/G873A polymorphism in the platelet glycoprotein Ia gene and the risk of acute coronary syndrome in the Italian population 120
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management 117
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy 117
Totale 19.938
Salva come PNG Salva come JPEG
Categoria #
all - tutte 125.977
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.977
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.551 150 91 43 70 104 39 35 221 90 127 261 320
2022/20233.215 436 436 243 476 226 378 182 241 316 89 134 58
2023/20242.681 84 452 125 172 150 302 162 115 105 266 367 381
2024/20255.876 358 271 446 286 462 205 266 254 698 641 1.096 893
2025/202612.628 1.651 493 902 1.320 1.892 645 1.905 692 896 882 683 667
2026/2027385 385 0 0 0 0 0 0 0 0 0 0 0
Totale 32.700